Most Hip Fracture Patients Aren't Getting Appropriate Medications.
Patients hospitalized for hip fracture rarely receive bone-strengthening medications afterward, according to a. JAMA Network Open study published in July 2018. The researchers based their findings on information from 2004-2015 files in a U.S. health claims database. They discovered that, in 2004, only 9.8 percent of the patients who had suffered a hip fracture had begun taking osteoporosis medications within 6 months after their fracture--and, alarmingly, that number dropped to 3.3 percent in 2015. Most hip fractures are the result of weak, brittle bones, or osteoporosis. Several medications are available for treating osteoporosis, including alendronate (Fosamax), ibandronate (Boniva), risedronate (Actonel), and zoledronate (Zometa). These medications work by inhibiting the breakdown of bone that is part of the ongoing process of bone metabolism. If you are 60 or older and you have not yet had a bone mineral density test, ask your doctor to order one for you. If you do have osteoporosis, discuss medication options with your doctor that can decrease your risk of fractures. All postmenopausal women should ensure they are getting adequate calcium, vitamin D, and other nutrients needed for strong bones, and they should engage in weight-bearing or "resistance" exercises at least twice a week.
|Printer friendly Cite/link Email Feedback|
|Publication:||Women's Health Advisor|
|Date:||Sep 1, 2018|
|Previous Article:||Non-Invasive Treatment May Help Multiple Sclerosis Patients.|
|Next Article:||More Warnings for Class of Antibiotic Drugs.|